Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

Share Price is delayed by 15 minutes
Get Live Data
88.70    -3.80 (-4.11%)
Bid:
88.70
Ask:
89.30
Spread: 0.60 (0.676%)
Market Cap: £615.99m
DATA Live PriceLast checked at - London Stock Exchange

Intraday GlobalData Share Chart

Board changes

19 Jan 2026 07:00

RNS Number : 3175P
GlobalData PLC
19 January 2026
 

19 January 2026

 

 

GlobalData Plc (GlobalData; the Company)Board changes

 

GlobalData Plc, a leading data, insights, and technology company, is pleased to announce the appointment of Rachel Higham as an independent non-executive director with effect from 20 January 2026.

Rachel brings to the board more than 30 years of experience in the information technology sector, having held senior roles at Marks & Spencer, WPP, BT and Vodafone.

In accordance with Schedule 2(g) of the AIM Rules for Companies, Rachel Higham is 51 years old. In the last 5 years she has been, and still is, a director at RHigham Consulting Limited and director and trustee at Macmillan Cancer Support. There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

This appointment is part of wider changes being announced with respect to the board's independent non-executive directorships. Both Annette Barnes and Andrew Day will not offer themselves for re-election as a director at the 2026 Annual General Meeting given they would, at that time, have served on the board for more than nine years from the date of their first appointment. Annette and Andrew will resign from office prior to the Company announcing its 2025 full year results on 2 March 2026.

Rachel is being appointed to succeed Andrew Day and a further appointment to succeed Annette Barnes is expected to be announced shortly. 

 

Mike Danson, Chief Executive Officer of GlobalData, commented:

"On behalf of the board, I would like to thank Annette and Andrew for their exceptional support and guidance over the last nine years during which time GlobalData has evolved into a globally recognised market leader. We wish them all the best for the future."

"I am also delighted to welcome Rachel to the GlobalData team. Rachel will bring a wealth of knowledge and expertise to our board both from her experiences within the technology sector, but also from her focus and passion for data and innovation.''

 

-ENDS-

 

 

ENQUIRIES

GlobalData Plc

0207 936 6400

Mike Danson, Chief Executive Officer

Graham Lilley, Chief Financial Officer

J.P. Morgan Cazenove (Nomad, Joint Broker)

0203 493 8000

Bill Hutchings

Mose Adigun

Panmure Liberum (Joint Broker)

0203 100 2000

Rupert Dearden

James Sinclair-Ford

 

Investec Bank plc (Joint Broker)

Henry Reast

0207 597 5970

Virginia Bull

FTI Consulting (Financial PR)

0203 727 1000

Edward Bridges

globaldata@fticonsulting.com

Dwight Burden

Emma Hall

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUQWGUPQPUQ
Date   Source Headline
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSTransaction in Own Shares
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 20247:00 amRNSTransaction in Own Shares
30th Sep 20247:00 amRNSTransaction in Own Shares
27th Sep 20247:00 amRNSTransaction in Own Shares
26th Sep 20247:00 amRNSTransaction in Own Shares
25th Sep 20247:00 amRNSTransaction in Own Shares
24th Sep 20247:00 amRNSTransaction in Own Shares
23rd Sep 20247:00 amRNSLaunch of Share Buyback Programme
6th Sep 20247:00 amRNSCompletion of Share Buyback Programme
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20245:21 pmRNSHolding(s) in Company
2nd Sep 20247:00 amRNSTransaction in Own Shares
30th Aug 20245:00 pmRNSUpdate on Acquisition
30th Aug 20243:38 pmRNSDirector/PDMR Shareholding
30th Aug 20243:37 pmRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
28th Aug 20247:00 amRNSTransaction in Own Shares
27th Aug 20247:00 amRNSTransaction in Own Shares
23rd Aug 20247:00 amRNSTransaction in Own Shares
22nd Aug 20247:00 amRNSTransaction in Own Shares
21st Aug 20242:52 pmRNSResults of General Meeting
21st Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:00 amRNSTransaction in Own Shares
19th Aug 20247:00 amRNSTransaction in Own Shares
16th Aug 20247:00 amRNSTransaction in Own Shares
16th Aug 20247:00 amRNSUpdate to Share Buyback Programme
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 20247:00 amRNSTransaction in Own Shares
9th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
5th Aug 20247:00 amRNSTransaction in Own Shares
2nd Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20247:00 amRNSPosting of Circular
1st Aug 20247:00 amRNSTransaction in Own Shares
31st Jul 20247:03 amRNSLaunch of Share Buyback Programme
31st Jul 20247:00 amRNSHalf Year Results
5th Jun 20247:00 amRNSUpdate re. Inflexion minority stake investment
2nd May 202410:16 amRNSDirector/PDMR Shareholding
2nd May 20247:00 amRNSAppointment of Joint Broker
23rd Apr 20242:44 pmRNSResults of Annual General Meeting
27th Mar 20247:00 amRNSAnnual Report for year ended 31 December 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.